Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer.
about
Postoperative adjuvant chemotherapy in rectal cancer operated for cureAdjuvant chemotherapy for rectal cancer: Is it needed?Pathologic Assessment of Rectal Carcinoma after Neoadjuvant Radio(chemo)therapy: Prognostic ImplicationsThe Need for Consensus and Transparency in Assessing Population-Based Rates of Positive Circumferential Radial Margins in Rectal Cancer: Data from Consecutive Cases in a Large Region of Ontario, Canada.Association between irrigation fluids, washout volumes and risk of local recurrence of anterior resection for rectal cancer: a meta-analysis of 427 cases and 492 controlsAllelotyping identification of genomic alterations in rectal chromosomally unstable tumors without preoperative treatment.Overview of radiation therapy for treating rectal cancer.Which is the best postoperative chemotherapy regimen in patients with rectal cancer after neoadjuvant therapy?Long-term survival and recurrence outcomes following surgery for distal rectal cancer.Impression of prognosis regarding pathologic stage after preoperative chemoradiotherapy in rectal cancer.Management of oligometastatic rectal cancer: is liver first?In colorectal liver metastases, the presence of extrahepatic disease correlates with the pathology of the primary tumour.Neoadjuvant treatment in rectal cancer: actual status.Sphincter-preserving surgery after preoperative radiochemotherapy for T3 low rectal cancersPretreatment high-resolution rectal MRI and treatment response to neoadjuvant chemoradiationExtramural depth of rectal cancer tumor invasion at thin-section MRI: predicting treatment response to neoadjuvant chemoradiation.Can only chemoradiotherapy and chemotherapy treatment be applied to patients with rectal cancer who could not be operated?Challenging the feasibility and clinical significance of current guidelines on lymph node examination in rectal cancer in the era of neoadjuvant therapy.Optimal timing of surgery after neoadjuvant chemoradiation therapy in locally advanced rectal cancer.A novel histologic grading scheme based on poorly differentiated clusters is applicable to treated rectal cancer and is associated with established histopathological prognosticators.Preoperative chemoradiotherapy in the management of localized rectal cancer: the new standard.Adjuvant chemoradiation for localized rectal cancer: current trends and future directionsMismatch Repair Gene Expression as a Predictor of Tumor Responses in Patients With Rectal Cancer Treated With Preoperative Chemoradiation.Risk factors for local recurrence of middle and lower rectal carcinoma after curative resection.Current issues in locally advanced colorectal cancer treated by preoperative chemoradiotherapyPathological complete response after neoadjuvant therapy for rectal cancer and the role of adjuvant therapy.Review on adjuvant chemotherapy for rectal cancer - why do treatment guidelines differ so much?Surgical Options in the Treatment of Lower Gastrointestinal Tract Cancers.A case for more intensive systemic therapy for patients with locally advanced rectal cancer: even in the face of a pathologic complete response.The Use of Re-irradiation in Locally Recurrent, Non-metastatic Rectal Cancer.Perineural Invasion Predicts for Distant Metastasis in Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiation and Surgery.The impact of surgical diversion before neoadjuvant therapy for rectal cancer.Neoadjuvant chemotherapy first, followed by chemoradiation and then surgery, in the management of locally advanced rectal cancer.Coexistence of perineural invasion and lymph node metastases is a poor prognostic factor in patients with locally advanced rectal cancer after preoperative chemoradiotherapy followed by radical resection and adjuvant chemotherapyOncologically safe distal resection margins in rectal cancer patients treated with chemoradiotherapy.Clinical implication of additional selective lateral lymph node excision in patients with locally advanced rectal cancer who underwent preoperative chemoradiotherapy.Postoperative adjuvant chemotherapy use in patients with stage II/III rectal cancer treated with neoadjuvant therapy: a national comprehensive cancer network analysis.Recurrence rates and prognostic factors in ypN0 rectal cancer after neoadjuvant chemoradiation and total mesorectal excision.Comparing pathological complete response rate using oral capecitabine versus infusional 5-fluorouracil with preoperative radiotherapy in rectal cancer treatment.Selecting patients for hyperthermia combined with preoperative chemoradiotherapy for locally advanced rectal cancer.
P2860
Q24201072-8C0B96DD-5BD2-412B-805B-62C97A310EEBQ26775099-603A3655-5EB6-4AD6-99C9-E8813A5A481AQ26778222-4C158728-E71E-4843-AC65-884BED719B62Q31006026-CC711989-F625-4722-9B32-E733874C8276Q33604428-431930FA-E5FF-418D-BA2C-D68DDB7FBDBFQ33721457-C9576224-406D-4AF5-9DDB-442969844A37Q34136267-F98A2823-DE3E-4A39-A955-55F7EAA1B361Q34630015-ADBE6158-A29D-4A65-9FB4-240450B9DD5FQ34766318-C265A052-06BB-43F4-8077-48F67A94A61BQ34932625-627F21C3-7C32-474C-A170-959199E2ABB1Q35029056-8320EDE7-BFBC-48AA-AAEB-496E68AAD89EQ35379752-814DF78C-AB87-4B3D-85E5-FD232230C47FQ35687452-DC3D7472-34D3-4340-9492-499197D7D55BQ36084304-262EB3F9-F67A-4386-9C5C-E9069094C2CFQ36537952-D6EBDABA-D22D-481F-86DE-3A1ADFE60171Q36557565-4B8B45FF-87A0-4B55-B9F8-74FB9D049B4BQ36792342-768F6CD5-AE5A-481E-82C2-9AAAF814D821Q36822151-85CB2058-2BB4-4A90-AF0F-847C7B9DE268Q36897686-634DCF13-4BB1-4E56-B45F-510A72EA6AB6Q36903261-7F0569AE-1AF7-40E5-93D2-4D4B32E173BCQ37077330-14603923-F0A9-4D15-B104-60887762C527Q37153288-C86270D0-861C-4ED3-93E5-DEFF87B03901Q37205031-FF9B0590-0C2A-43CD-B51D-1CB903A7A7D3Q37336425-B8DF6D84-3836-4A30-8CFA-D5D1ED5F8D06Q37602735-A45D85F0-2210-4D33-8901-986971AF25D7Q38079162-1FB9DC5B-50F6-4639-8139-A74C543EBBC5Q38322257-0198F999-0C4E-494C-92D9-F7808AA12303Q38549935-76AE1718-6C7B-42E5-81F2-DC62ABF53EA4Q38827282-80EB7ADA-4DCC-478E-BDD7-791D47BA08CDQ39172762-8DCFB9CE-49E3-4B84-A2D9-95E3699493B3Q40171741-66E41E46-DC7D-4F9B-B5E8-BAE7C52CC6B4Q40939163-12D62ECC-5FC5-4711-8ACE-A17CB53F95F7Q41692918-25F3C28E-1430-401A-9FFF-B2099607AF97Q42759312-883486A6-002B-45C5-AF4F-4699B109EE92Q43579125-8728973D-AD28-4F0C-A74A-BC7A64131D72Q45219204-4E6D29CF-F63F-4395-AD7C-E0F0B4DCAD4EQ45783553-AFD18DE3-92AA-46A6-B84C-9CE85BE4F173Q46883395-9AE2FA12-F548-45DD-AC1B-3FEFBA820AEEQ47856887-A22A5FA6-8F86-4438-86FB-F5E73A0B9535Q48310789-36455CB2-B0F9-47CC-BC9A-B063D5C71A10
P2860
Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Clinical and pathologic predic ...... al excision for rectal cancer.
@en
Clinical and pathologic predic ...... al excision for rectal cancer.
@nl
type
label
Clinical and pathologic predic ...... al excision for rectal cancer.
@en
Clinical and pathologic predic ...... al excision for rectal cancer.
@nl
prefLabel
Clinical and pathologic predic ...... al excision for rectal cancer.
@en
Clinical and pathologic predic ...... al excision for rectal cancer.
@nl
P2093
P1476
Clinical and pathologic predic ...... al excision for rectal cancer.
@en
P2093
Barry W Feig
Christopher H Crane
George J Chang
John M Skibber
Lawrence B Levy
Lee M Ellis
Marc E Delclos
Miguel A Rodriguez-Bigas
Nora A Janjan
P304
P356
10.1097/01.COC.0000214930.78200.4A
P577
2006-06-01T00:00:00Z